-
Mashup Score: 0APA: Americans Are Stressed, Particularly Young Adults - 4 year(s) ago
American Psychological Association says annual survey points to national mental health crisis
Source: Physician's BriefingCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Physician's Briefing Weekly Coronavirus Roundup - 4 year(s) ago
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 19 to 23, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Source: Physician's BriefingCategories: Healthcare Professionals, Latest HeadlinesTweet-
The week in COVID-19: Here’s what doctors are being told about the most important COVID research for the week of Oct. 19 to 23, 2020. https://t.co/89ByFewC1z
-
-
Mashup Score: 0
Labeling must indicate risks to unborn baby with NSAID use at 20 weeks of pregnancy or later
Source: Physician's BriefingCategories: Healthcare Professionals, Latest HeadlinesTweet-
Best of: FDA says labels for pain meds (NSAIDs) must change to warn women of the dangers of taking these over-the-counter drugs during pregnancy. https://t.co/HI9frrEVNz
-
-
Mashup Score: 0
Labeling must indicate risks to unborn baby with NSAID use at 20 weeks of pregnancy or later
Source: Physician's BriefingCategories: Healthcare Professionals, Latest HeadlinesTweet-
FDA says labels for pain meds (known as NSAIDs) must be changed to warn women of the dangers of taking these over-the-counter drugs during pregnancy. https://t.co/HI9frrEVNz
-
-
Mashup Score: 0Physician's Briefing Weekly Coronavirus Roundup - 4 year(s) ago
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 12 to 16, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Source: Physician's BriefingCategories: Healthcare Professionals, Latest HeadlinesTweet-
The week in COVID-19: Here’s what doctors are being told about the most important COVID research for the week of Oct. 12 to 16, 2020. https://t.co/hhbwWg5IF0
-
-
Mashup Score: 0Remdesivir Cuts Time to COVID-19 Recovery - 4 year(s) ago
However, no significant difference in mortality found between remdesivir and placebo groups
Source: Physician's BriefingCategories: Healthcare Professionals, Latest HeadlinesTweet-
Best of: Double-blind, placebo-controlled trial suggests remdesivir reduces days in the hospital for COVID-19 and prevents progression to more severe disease. https://t.co/GJFf8bWj39
-
-
Mashup Score: 0Sitagliptin May Cut Mortality in T2DM Patients With COVID-19 - 4 year(s) ago
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Source: Physician's BriefingCategories: Healthcare Professionals, Latest HeadlinesTweet-
Best of: People taking this drug for type 2 diabetes seem to be less likely to die and recover quicker from COVID-19. https://t.co/YCcVjgm9rQ
-
-
Mashup Score: 0One Size May Not Fit All for Postoperative Opioid Prescribing - 4 year(s) ago
Guidelines reduce postoperative opioid prescribing but may result in inadequate pain control for some
Source: Physician's BriefingCategories: Latest Headlines, SurgeryTweet-
Researchers from @sloan_kettering surveyed patients after surgery and found evidence-based guidelines successfully reduce postoperative opioid prescriptions, but there may be a small subset of patients who are not getting optimal pain control. Read more: https://t.co/traqsiUdTe
-
-
Mashup Score: 0Black Race Tied to COVID-19 Admissions, but Not Deaths - 4 year(s) ago
In-hospital mortality higher for Asian patients, despite lower risk for hospital admission
Source: Physician's BriefingCategories: Healthcare Professionals, Latest HeadlinesTweet-
Race seems to be a factor in risk of hospitalization for COVID-19 but may not influence risk of death. https://t.co/sEc3VBnD6P
-
-
Mashup Score: 1Sitagliptin May Cut Mortality in T2DM Patients With COVID-19 - 4 year(s) ago
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Source: Physician's BriefingCategories: Healthcare Professionals, Latest HeadlinesTweet-
People taking this drug for type 2 diabetes seem to be less likely to die, and recover quicker, from COVID-19. https://t.co/YCcVjgm9rQ
-
Annual survey points to national mental health crisis, particularly among young adults. https://t.co/9d67Yy036a